ClinicalTrials.gov
ClinicalTrials.gov Menu

Chinese Adolescent Registry for Diabetes (CARD) Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02950272
Recruitment Status : Recruiting
First Posted : November 1, 2016
Last Update Posted : November 1, 2016
Sponsor:
Information provided by (Responsible Party):
Qilu Hospital of Shandong University

Brief Summary:
The CARD study is a observational study which includes Chinese adolescents with diabetes aged 18-30. The study aims to explore the status of disease treatment, self-management, the relationship between disease treatment and disease outcome in Chinese adolescents with diabetes.

Condition or disease
Chinese Adolescents With Diabetes

Study Type : Observational [Patient Registry]
Estimated Enrollment : 1500 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 6 Years
Study Start Date : September 2016
Estimated Primary Completion Date : September 2022



Primary Outcome Measures :
  1. cardiovascular events [ Time Frame: six year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chinese adolescents with diabetes aged 14-30.
Criteria

Inclusion Criteria:

  • diagnosed diabetes
  • aged 14-30
  • signed the informed consent

Exclusion Criteria:

  • taking part in other drug research
  • gestational diabetes
  • diagnosed with tumor or cardiovascular disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02950272


Locations
China, Shandong
Qilu Hospital of Shandong University Recruiting
Jinan Shi, Shandong, China, 250012
Contact: Guo X Hou, Doctor    18560080308    houxinguo@medmail.com.cn   
Contact: Chuan Wang, Doctor    18560088309    1175533920@qq.com   
Sponsors and Collaborators
Qilu Hospital of Shandong University

Responsible Party: Qilu Hospital of Shandong University
ClinicalTrials.gov Identifier: NCT02950272     History of Changes
Other Study ID Numbers: CARD-QiluH
First Posted: November 1, 2016    Key Record Dates
Last Update Posted: November 1, 2016
Last Verified: October 2016